Volume 10, Number 5—May 2004
Research
Causative Agent of Pogosta Disease Isolated from Blood and Skin Lesions
Table
Patient | Strain | Sample | Sex | Age (y) | Probable place of exposure | Onset of symptoms | Disease/rash days at time of sampling | SINV IgM status at time of sampling | |
---|---|---|---|---|---|---|---|---|---|
1 |
Ilomantsi-2002A |
Skin lesion |
M |
35 |
Ilomantsi, Finland |
8/ 22/2002 |
3/ 1 |
Negative |
|
2 |
Ilomantsi-2002B |
Skin lesion |
M |
30 |
Ilomantsi, Finland |
8/18/2002 |
2/ 0 |
Negative |
|
3 |
Ilomantsi-2002C |
Whole blood |
F |
47 |
Ilomantsi, Finland |
Late Aug. 2002 |
N/A |
Borderline |
|
4 |
Johannes-2002 |
Skin lesion |
M |
63 |
Johannes, Russia |
8/27/2002 |
9/7 |
N/A |
|
5 | Kiihtelysvaara-2002 | Skin lesion | M | 39 | Kiihtelysvaara, Finland | 8/30/2002 | 3/ 2 | Negative |
aThe places of exposure are shown on the map (Figure 1). The representative case report given in the text describes the patient from whom the Ilomantsi-2002A virus strain was recovered.
bM, male; F, female; N/A, not available; Ig, immunoglobulin.
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.